MetLife Investment Management, LLC - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$198,706
+19.7%
53,130
+36.6%
0.00%
+100.0%
Q2 2023$166,065
-46.1%
38,8910.0%0.00%
-50.0%
Q4 2022$308,017
-17.6%
38,8910.0%0.00%
-33.3%
Q3 2022$373,743
+48.0%
38,891
+11.5%
0.00%
+50.0%
Q2 2022$252,589
-43.9%
34,8880.0%0.00%
-33.3%
Q1 2022$450,404
+32.3%
34,888
+63.6%
0.00%0.0%
Q4 2021$340,331
-0.7%
21,3240.0%0.00%0.0%
Q3 2021$342,677
+10.0%
21,3240.0%0.00%0.0%
Q1 2021$311,544
-40.2%
21,324
-24.9%
0.00%
-50.0%
Q3 2020$520,966
+2.7%
28,4060.0%0.01%0.0%
Q2 2020$507,331
-0.8%
28,4060.0%0.01%
+20.0%
Q4 2019$511,45028,4060.01%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 568,408$2,125,84618.08%
CM Management, LLC 548,000$2,049,5202.18%
AlphaCentric Advisors LLC 912,500$3,412,7501.94%
Knott David M Jr 630,000$2,3560.90%
COURAGE CAPITAL MANAGEMENT LLC 50,000$1870.63%
Bridge City Capital, LLC 276,224$1,033,0780.52%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$11,354,9240.40%
Ikarian Capital, LLC 865,787$3,238,0430.39%
Aristotle Capital Boston, LLC 2,342,977$8,762,7340.28%
TANG CAPITAL MANAGEMENT LLC 400,000$1,496,0000.21%
View complete list of COHERUS BIOSCIENCES INC shareholders